The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $159.28

Today's change-2.73 -1.69%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $159.28

Today's change-2.73 -1.69%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.

Sharp drop following new 52-week high

Jazz Pharmaceuticals PLC closed sharply lower Friday, dropping (U.S.)$2.73 or 1.69% to (U.S.)$159.28 after setting a new 52-week high. Over the last five days, shares have gained 4.21% and are currently 2.73% off of the 52-week high. Shares have underperformed the S&P 500 by 10.07% during the last year.

Key company metrics

  • Open(U.S.) $163.33
  • Previous close(U.S.) $162.01
  • High(U.S.) $163.75
  • Low(U.S.) $158.80
  • Bid / Ask(U.S.) $103.07 / (U.S.) $0.00
  • YTD % change+46.09%
  • Volume439,054
  • Average volume (10-day)422,309
  • Average volume (1-month)608,107
  • Average volume (3-month)608,090
  • 52-week range(U.S.) $95.80 to (U.S.) $163.75
  • Beta1.26
  • Trailing P/E24.81×
  • P/E 1 year forward14.32×
  • Forward PEG0.80×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $6.42
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.51%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue397374381336
Total other revenue--------
Total revenue397374381336
Gross profit363350357313
Total cost of revenue34242423
Total operating expense231239212215
Selling / general / administrative126124123129
Research & development44633940
Depreciation / amortization26262723
Interest expense (income), net operating--------
Unusual expense (income)210--
Other operating expenses, total--------
Operating income166136169121
Interest income (expense), net non-operating-19-18-12-12
Gain (loss) on sale of assets--------
Other--------
Income before tax151116157108
Income after tax1248711174
Income tax, total27294534
Net income1248711174
Total adjustments to net income--------
Net income before extra. items1248711174
Minority interest000--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1248711174
Inc. avail. to common incl. extra. items1248711174
Diluted net income1248711174
Dilution adjustment----00
Diluted weighted average shares62626262
Diluted EPS excluding extraordinary itemsvalue per share2.021.411.801.19
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share2.041.421.801.16